Kliniske studier for KOLS i Florida
28 studier for KOLS søker deltakere på steder i Florida.
Byer i Florida
- Miami18 studier
- Orlando15 studier
- Hialeah8 studier
- Tampa7 studier
- Kendall7 studier
- Jacksonville6 studier
- West Palm Beach6 studier
- Ocala5 studier
- St. Petersburg4 studier
- Deltona4 studier
- Doral4 studier
- Boca Raton4 studier
- Brandon3 studier
- Plantation3 studier
- Cape Coral3 studier
- Clearwater3 studier
- Palm Coast3 studier
- Naples3 studier
Offisiell studietekst (engelsk)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boynton Beach
- Research Site, Bradenton
- Research Site, Cape Coral
- og 25 flere
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Meris Clinical Research- Site Number : 8400153, Brandon
- Hillcrest Medical Research- Site Number : 8400082, DeLand
- Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
- og 18 flere
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- International Clinical Research, Altamonte Springs
- Nature Coast Clinical Research, Crystal River
- Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
- og 2 flere
RekruttererFase 2
Alder 40 til 85 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07684820A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, Miami
- GSK Investigational Site, Tampa
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07780656A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
RekruttererFase 2
Alder 40 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Helix Biomedics- Site Number : 8400065, Boynton Beach
- Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
- Eastern Medical Group Research- Site Number : 8400020, Fort Myers
- og 10 flere
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
RekruttererFase 4
Alder 40 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07053423A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Helix Biomedics- Site Number : 8403065, Boynton Beach
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Orlando Health, Orlando
Rekrutterer
Alder 40 til 80 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Miami Lakes
RekruttererFase 2
Alder 40 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07646587A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Doral
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Brandon
- Research Site, Cape Coral
- Research Site, Clearwater
- og 17 flere
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Bay Pines
- Research Site, Boynton Beach
- Research Site, Jacksonville
- og 5 flere
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearwater
- Research Site, Cutler Bay
- Research Site, Cutler Bay
- og 9 flere
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Finlay Medical Research, Greenacres City
- Clinical Research Specialists LLC, Kissimmee
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- og 9 flere
RekruttererFase 2/3
Alder 35 til 80 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07363694Rademikibart IV for Acute Asthma and COPD Exacerbation
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
RekruttererFase 2
Alder 18 til 85 · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07705737Alpha-1 Research Registry
- Alpha-1 Foundation, Coral Gables
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04157049A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT07555483STRIVE Post-Market Registry Study
- University of Miami, Coral Gables
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 3. aug. 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Brandon
- GSK Investigational Site, Crystal River
- GSK Investigational Site, Doral
- og 8 flere
RekruttererFase 3
Alder 40 til 75 · Alle kjønn · Oppdatert 28. jul. 2026 · NCT07177339Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- University of Miami, Miami
Rekrutterer
Alder 18 til 100 · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06578156Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Mayo Clinic Jacksonville, Jacksonville
Rekrutterer
Alder 40 til 80 · Alle kjønn · Oppdatert 28. apr. 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Mayo Clinic, Jacksonville
- Orlando Health, Orlando
Rekrutterer
Alder 40 til 84 · Alle kjønn · Oppdatert 24. apr. 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Brooksville
- GSK Investigational Site, Doral
- GSK Investigational Site, Fort Lauderdale
- og 15 flere
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Loxahatchee Groves
- GSK Investigational Site, Miami
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 8. okt. 2025 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hillcrest Medical Research, DeLand
- Universal Axon Clinical Research, Doral
- I.H.S Health, LLC, Kissimmee
- og 3 flere
RekruttererObservasjonsstudie
Alder 50 og eldre · Alle kjønn · Oppdatert 5. aug. 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Florida, Jacksonville, Jacksonville
- Alloy Clinical Research, Kissimmee
- Reliable Research, Inc., Miami
- og 2 flere
Rekrutterer
Alder 30 og eldre · Alle kjønn · Oppdatert 6. feb. 2025 · NCT05204888Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.